C. Wijmenga, J. E. Hewitt, L. A. Sandkuijl, L. N. Clark, and T. J. Wright, Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy, Nat Genet, vol.2, pp.26-30, 1992.

J. E. Hewitt, R. Lyle, L. N. Clark, E. M. Valleley, and T. J. Wright, Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy, Hum Mol Genet, vol.3, pp.1287-1295, 1994.

S. M. Van-der-maarel, R. R. Frants, and G. W. Padberg, Facioscapulohumeral muscular dystrophy, Biochim Biophys Acta, vol.1772, pp.186-194, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00480367

J. C. De-greef, R. Lemmers, B. Van-engelen, S. Sacconi, and S. L. Venance, Common epigenetic changes of D4Z4 in contraction-dependent and contraction-independent FSHD, Hum Mutat, vol.30, pp.1449-1459, 2009.

J. C. De-greef, R. Lemmers, P. Camano, J. W. Day, and S. Sacconi, Clinical features of facioscapulohumeral muscular dystrophy 2, Neurology, vol.75, pp.1548-1554, 2010.

H. Ding, M. Beckers, S. Plaisance, P. Marynen, and D. Collen, Characterization of a double homeodomain protein (DUX1) encoded by a cDNA homologous to 3.3 kb dispersed repeated elements, Hum Mol Genet, vol.7, pp.1681-1694, 1998.

J. Gabriëls, M. C. Beckers, H. Ding, D. Vriese, A. Plaisance et al., Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element, Gene, vol.236, pp.25-32, 1999.

M. Dixit, E. Ansseau, A. Tassin, S. Winokur, and R. Shi, DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1, Proc Natl Acad Sci U S A, vol.104, pp.18157-18162, 2007.

R. Lemmers, P. J. Van-der-vliet, R. Klooster, S. Sacconi, and P. Camano, A unifying genetic model for facioscapulohumeral muscular dystrophy, Science, vol.329, pp.1650-1653, 2010.

L. Snider, A. Asawachaicharn, A. E. Tyler, L. N. Geng, and L. M. Petek, RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy, Hum Mol Genet, vol.18, pp.2414-2430, 2009.

L. Snider, L. N. Geng, R. Lemmers, M. Kyba, and C. B. Ware, Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene, PLoS Genet, vol.6, p.1001181, 2010.

M. Kawamura-saito, Y. Yamazaki, K. Kaneko, N. Kawaguchi, and H. Kanda, Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation, Hum Mol Genet, vol.15, pp.2125-2137, 2006.

V. Kowaljow, A. Marcowycz, E. Ansseau, C. B. Conde, and S. Sauvage, The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein, Neuromuscul Disord, vol.17, pp.611-623, 2007.

M. Richards, F. Coppée, N. Thomas, A. Belayew, and M. Upadhyaya, Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled? Human Genetics, 2011.

C. Lanctôt, A. Moreau, M. Chamberland, and M. L. Tremblay, Hindlimb patterning and mandible development require the Ptx1 gene, Development, vol.126, pp.1805-1810, 1999.

M. Dixit, R. Shi, M. Sutherland, S. Munger, and Y. Chen, Characterization of a tet-repressible muscle-specific Pitx1 transgenic mouse model as an animal model of FSHD, FASEB Journal, vol.21, pp.870-878, 2007.

D. Bosnakovski, Z. Xu, E. J. Gang, C. L. Galindo, and M. Liu, An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies, EMBO J, vol.27, pp.2766-2779, 2008.

L. M. Wallace, S. E. Garwick, W. Mei, A. Belayew, and F. Coppee, DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo, Ann Neurol, vol.69, pp.540-552, 2010.

D. X. Liu and P. E. Lobie, Transcriptional activation of p53 by Pitx1, Cell Death Differ, vol.14, pp.1893-1907, 2007.

E. Ansseau, D. Laoudj-chenivesse, A. Marcowycz, A. Tassin, and C. Vanderplanck, DUX4c is up-regulated in FSHD. It induces the MYF5 protein and human myoblast proliferation, PLoS ONE, vol.4, p.7482, 2009.

P. S. Masny, O. Y. Chan, J. C. De-greef, U. Bengtsson, and M. Ehrlich, Analysis of allele-specific RNA transcription in FSHD by RNA-DNA FISH in single myonuclei, Eur J Hum Genet, vol.18, pp.448-456, 2010.

D. Gabellini, D. 'antona, G. Moggio, M. Prelle, A. Zecca et al., Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1, Nature, vol.439, pp.973-977, 2006.

M. Barro, G. Carnac, S. Flavier, J. Mercier, and Y. Vassetzky, Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects, J Cell Mol Med, vol.14, pp.275-289, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00284424

L. De-palma, M. Marinelli, M. Pavan, and A. Orazi, Ubiquitin ligases MuRF1 and MAFbx in human skeletal muscle atrophy, Joint Bone Spine, vol.75, pp.53-57, 2008.

J. Lagirand-cantaloube, K. Cornille, A. Csibi, S. Batonnet-pichon, and M. P. Leibovitch, Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo, PLoS ONE, vol.4, p.4973, 2009.

P. W. Reed, A. M. Corse, N. C. Porter, K. M. Flanigan, and R. J. Bloch, Abnormal expression of mu-crystallin in facioscapulohumeral muscular dystrophy, Exp Neurol, vol.205, pp.583-586, 2007.

S. D. Wilton, A. M. Fall, P. L. Harding, G. Mcclorey, and C. Coleman, Antisense oligonucleotide-induced exon skipping across the human dystrophin gene transcript, Mol Ther, vol.15, pp.1288-1296, 2007.

S. Fletcher, A. M. Adams, R. D. Johnsen, K. Greer, and H. M. Moulton, Dystrophin isoform induction in vivo by antisense-mediated alternative splicing, Mol Ther, vol.18, pp.1218-1223, 2010.

S. D. Wilton, F. Lloyd, K. Carville, S. Fletcher, and K. Honeyman, Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides, Neuromuscular Disorders, vol.9, pp.330-338, 1999.

S. J. Errington, C. J. Mann, S. Fletcher, and S. D. Wilton, Target selection for antisense oligonucleotide induced exon skipping in the dystrophin gene, J Gene Med, vol.5, pp.518-527, 2003.

R. Klooster, K. Straasheijm, B. Shah, J. Sowden, and R. Frants, Comprehensive expression analysis of FSHD candidate genes at the mRNA and protein level, Eur J Hum Genet, vol.17, pp.1615-1624, 2009.

M. P. Vie, C. Evrard, J. Osty, A. Breton-gilet, and P. Blanchet, Purification, molecular cloning, and functional expression of the human nicodinamideadenine dinucleotide phosphate-regulated thyroid hormone-binding protein, Mol Endocrinol, vol.11, 1997.

G. E. Muscat, M. Downes, and D. H. Dowhan, Regulation of vertebrate muscle differentiation by thyroid hormone: the role of the myoD gene family, BioEssays, vol.17, pp.211-218, 1995.

R. Tawil and S. M. Van-der-maarel, Facioscapulohumeral muscular dystrophy, Muscle Nerve, vol.34, pp.1-15, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00770764

S. T. Winokur, K. Barrett, J. H. Martin, J. R. Forrester, and M. Simon, Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress, Neuromuscul Disord, vol.13, pp.322-333, 2003.

F. Casas, L. Pessemesse, S. Grandemange, P. Seyer, and O. Baris, Overexpression of the mitochondrial T3 receptor induces skeletal muscle atrophy during aging, Plos One, vol.5, 2009.
URL : https://hal.archives-ouvertes.fr/hal-02156261

R. Y. Kim, R. Gasser, and G. J. Wistow, mu-Crystallin is a mammalian homologue of Agrobacterium ornithine cyclodeaminase and is expressed in human retina, Proc Natl Acad Sci, vol.89, pp.9292-9296, 1992.

S. Umeda, M. T. Suzuki, H. Okamoto, F. Ono, and A. Mizota, Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis), FASEB J, vol.19, pp.1683-1685, 2005.

A. Oshima, S. Suzuki, Y. Takumi, K. Hashizume, and S. Abe, CRYM mutations cause deafness through thyroid hormone binding properties in the fibrocytes of the cochlea, J Med Genet, vol.43, p.25, 2006.

G. W. Padberg, O. F. Brouwer, R. J. De-keizer, G. Dijkman, and C. Wijmenga, On the significance of retinal vascular disease and hearing loss in facioscapulohumeral muscular dystrophy, Muscle Nerve, vol.2, pp.73-80, 1995.

C. L. Brooks and W. Gu, ubiquitination: Mdm2 and beyond, Mol Cell, vol.21, pp.307-315, 2006.

O. Maddocks and K. H. Vousden, Metabolic regulation by p53, J Mol Med, vol.89, pp.237-245, 2011.

D. A. Braasch, S. Jensen, Y. Liu, K. Kaur, and K. Arar, RNA interference in mammalian cells by chemically-modified RNA, Biochem, vol.42, pp.7967-7975, 2003.

A. Amantana and P. L. Iversen, Pharmacokinetics and biodistribution of phosphorodiamidate morpholino antisense oligomers, Curr Opin Pharmacol, vol.5, pp.550-555, 2005.

T. S. Deas, I. Binduga-gajewska, M. Tilgner, P. Ren, and D. A. Stein, Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication, J Virol, vol.79, pp.4599-4609, 2005.

T. A. Vickers, J. R. Wyatt, T. Burckin, C. F. Bennett, and S. M. Freier, Fully modified 29MOE oligonucleotides redirect polyadenylation, Nucleic Acids Res, vol.29, pp.1293-1299, 2001.

R. Lemmers, M. Wohlgemuth, R. R. Frants, G. W. Padberg, and E. Morava, Contractions of D4Z4 on 4qB subtelomeres do not cause Facioscapulohumeral Muscular Dystrophy, Am J Hum Genet, vol.75, pp.1124-1130, 2004.

C. H. Zhu, V. Mouly, R. N. Cooper, K. Mamchaoui, and A. Bigot, Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies, Aging Cell, vol.6, pp.515-523, 2007.

C. J. Mann, K. Honeyman, G. Mcclorey, S. Fletcher, and S. D. Wilton, Improved antisense oligonucleotide induced exon skipping in the mdx mouse model of muscular dystrophy, J Gene Med, vol.4, pp.644-654, 2002.